2614W94
CAS No. 205187-35-5
2614W94 ( —— )
产品货号. M26022 CAS No. 205187-35-5
2614W94 is a selective, competitive, and reversible inhibitor of monoamine oxidase-A with IC50 of 5 nM and Ki of 1.6 nM with serotonin as a substrate.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥4026 | 有现货 |
|
10MG | ¥5856 | 有现货 |
|
25MG | ¥9153 | 有现货 |
|
50MG | ¥12312 | 有现货 |
|
100MG | ¥16038 | 有现货 |
|
500MG | ¥32157 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称2614W94
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述2614W94 is a selective, competitive, and reversible inhibitor of monoamine oxidase-A with IC50 of 5 nM and Ki of 1.6 nM with serotonin as a substrate.
-
产品描述2614W94 is a selective, competitive, and reversible inhibitor of monoamine oxidase-A with IC50 of 5 nM and Ki of 1.6 nM with serotonin as a substrate.(In Vitro):2614W94 (30 nM) shows no inhibition of MAO-B.(In Vivo):In rats, 2614W94 (5 mg/kg, p.o.) selectively inhibits MAO-A in brains and livers and elevates neurotransmitter amines in brain, inparticular serotonin and norepinephrine, with a redcution of their oxidized metabolites. 2614W94 (0.5, 1, 2 mg/kg, p.o.) dose-dependently potentiates 5-hydroxytryptophan-induced head twitches with an extrapolated ED50 of 1.1 mg/kg.
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体Alkyl-Chain
-
研究领域——
-
适应症——
化学信息
-
CAS Number205187-35-5
-
分子量344.3
-
分子式C15H11F3O4S
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESCC(Oc1ccc2c(Oc3ccccc3S2(=O)=O)c1)C(F)(F)F
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562.
产品手册
关联产品
-
Methyl nomilinate
Methyl nomilinate from citrus can modulate cell cycle regulators to induce cytotoxicity in human colon cancer (SW480) cells in vitro.
-
Cadralazine
Cadralazine is a peripheral arteriolar vasodilator and can be used in studies about acting as an antihypertensive drug.
-
Methyl nomilinate
Methyl nomilinate from citrus can modulate cell cycle regulators to induce cytotoxicity in human colon cancer (SW480) cells in vitro.